Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers will add a van and a minivan to its model range

10/18/24 SVAV

Board of Directors of SFI recommended dividends

10/18/24 SFIN

Southern Kuzbass reported for 9 months of 2024 by RAS

10/18/24 UKUZ

Sminex closed the acquisition of Ingrad

10/17/24 INGR

KuibyshevAzot reported for 9 months of 2024 by RAS

10/17/24 KAZT

Softline is preparing a buyback

10/17/24 SOFL

Rosgosstrakh reported for 9 months of 2024 by RAS

10/17/24 RGSS

RSC Energia reported for 9 months of 2024 by RAS

10/17/24 RKKE

Zaimer in Q3 increased the issuance of medium-term loans by 77%

10/17/24 ZAYM

MMK's sales for 9 months decreased by 7.1%

10/17/24 MAGN